Sharemaestro Newsreel

Aytu BioPharma Market Sentiment

This article analyzes market sentiment for Aytu BioPharma (AYTU), covering analyst consensus, short interest, options flow, and insider activity. Analysts currently have a "Buy" consensus with an average price target significantly above the current stock price, and there's a declining short interest. Recent insider …

Aquestive Therapeutics Inc (AQST) Institutional Confidence

Aquestive Therapeutics Inc (AQST) has an institutional shareholding score of 5.00, placing it 72nd within the Pharmaceuticals industry. Institutional investors collectively hold 60.30% of the shares, marking a 16.75% increase quarter-over-quarter. Bill Nygren | OAKMX is the largest institutional shareholder, holding 912.50K shares.

ANIK|Anika Therapeutics Inc|Price:15.200|Chg%:+0.180

This article provides a comprehensive stock analysis of Anika Therapeutics Inc (ANIK) by TradingKey. It highlights the company's strong fundamentals, high growth potential, and fair valuation within the Healthcare Equipment & Supplies industry. The analysis also notes high institutional ownership and a "Strong Buy" …

Amylyx Pharmaceuticals Inc (AMLX) Cash Flow

This article provides a detailed cash flow statement for Amylyx Pharmaceuticals Inc (AMLX), covering quarterly and annual data from FY2020Q4 to FY2026Q1 across operating, investing, and financing activities. It presents financial figures in USD, highlighting net income, capital expenditures, and changes in working capital. …

Amylyx Pharmaceuticals Inc (AMLX) Valuation: PE, PB & Fair Value Analysis

Amylyx Pharmaceuticals Inc (AMLX) has a current valuation score of 8.13, placing it 163rd out of 386 in the Biotechnology & Medical Research industry. Its P/E ratio stands at -13.13, which is significantly below its recent high but above its recent low. The company …

Redhill Biopharma Ltd (RDHL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article discusses Redhill Biopharma Ltd (RDHL) revenue breakdown but states that relevant data regarding business segments, regional revenue, and profit contribution have not been disclosed by the company yet. It provides current stock information, including the price, market cap, and P/E TTM. The …

Total operating expenses of Ironwood Pharmaceuticals, Inc. Class A – HAM:I76

This article states the total operating expenses for Ironwood Pharmaceuticals, Inc. Class A, traded on the Hamburg Stock Exchange under the ticker I76. It indicates that the market is closed with no current trades. Further financial details would be available in a dedicated "Financials" …

Cronos Group Inc. stock rises Monday, outperforms market

Shares of Cronos Group Inc. (CRON) rose 1.78% to $2.86 on Monday, marking its second consecutive day of gains. The stock's performance outpaced the broader market, as the Dow Jones Industrial Average gained 0.51% while the NASDAQ Composite Index fell 0.18%.

Aurora Cannabis Inc. stock rises Monday, outperforms market

Aurora Cannabis Inc. (ACB) saw its stock rise by 2.62% on Monday, closing at $2.74. This performance outpaced the broader market, as the Dow Jones Industrial Average gained 0.51% while the NASDAQ Composite Index fell by 0.18%. Despite the daily gain, the stock remains …

SCYNEXIS Inc (SCYX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of SCYNEXIS Inc (SCYX), detailing its current price momentum, support and resistance levels, and various technical indicator readings. It also includes an analysis of moving averages and offers a summary of signals based on these technical tools. The …

Zhengye Biotechnology Holding Ltd (ZYBT) Balance Sheet

This article provides the balance sheet for Zhengye Biotechnology Holding Ltd (ZYBT), offering detailed quarterly and annual financial data. It covers various financial components such as assets, liabilities, and shareholders' equity, alongside FAQs explaining key financial metrics and their relevance for investors. The information …

Takeda (TSE:4502) Stock Looks Below Fair Value While Broader Checks Stay Mixed

Takeda Pharmaceutical stock has returned 91.4% over the past 5 years and appears undervalued on market multiples, yet broader valuation checks are mixed. The company's P/S ratio of 2.0x is below the model-based fair ratio of 3.4x, suggesting it's undervalued on sales despite recent …

Will Supernus (SUPN) Beat Estimates Again in Its Next Earnings Report?

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Supernus Pharmaceuticals (SUPN). This company, which is in the Zacks …

SIGA Technologies Inc (SIGA) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of SIGA Technologies Inc (SIGA), highlighting its current valuation score and financial ratios. The company's valuation score is 5.26, ranking low within the Pharmaceuticals industry. It also details SIGA's current P/E ratio, noting its position relative to recent …

Pacira enrolls first patient in Phase 2 ASCEND Part B trial of knee osteoarthritis gene therapy PCRX-201

Pacira Biosciences has enrolled the first patient in Part B of its Phase 2 ASCEND trial for PCRX-201, an investigational gene therapy for knee osteoarthritis. This milestone follows the transition to a U.S.-based commercial-scale manufacturing process. Topline results for Part A of the study, …

Amphastar Pharmaceuticals Inc (AMPH) Cash Flow

This article provides a detailed cash flow statement for Amphastar Pharmaceuticals Inc (AMPH), covering annual and quarterly data across operating, investing, and financing activities. It presents financial figures for various cash flow components from FY2012Q4 to FY2026Q1, including net income, capital expenditures, and changes …

Sonoma Pharmaceuticals Inc (SNOA) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Sonoma Pharmaceuticals Inc (SNOA)'s dividend history and stock split events. It states that the company has distributed $0.00 in dividends over the past five years and details multiple 20-to-1 merger-related stock splits scheduled for August 28, 2024. The …

Neurocrine Gears Up to Report Q2 Earnings: What's in the Cards?

Neurocrine Biosciences (NBIX) is slated to report its second-quarter 2026 earnings on July 30, with investors keenly focused on the sales performance of its key products, Ingrezza and Crenessity, and updates on its neuroscience pipeline. The Zacks Consensus Estimate projects revenues of $901.54 million …

JPMorgan discloses 6.3% Neurocrine stake in 13G/A filing (NBIX)

JPMorgan Chase & Co. has filed an amended Schedule 13G/A, reporting a beneficial ownership of 6.3% in Neurocrine Biosciences, Inc. common stock, totaling 6,338,240 shares. The filing details JPMorgan's sole voting power over 5,719,691 shares and sole dispositive power over 6,337,388 shares. This disclosure …

Redhill Biopharma Ltd (RDHL) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Redhill Biopharma Ltd (RDHL), stating that its current valuation score is 9.96, ranking 1st in the Pharmaceuticals industry. It highlights the company's P/E ratio of -7.00, which is significantly below its recent high. However, other key financial …

Rockwell Medical Inc (RMTI) Cash Flow

This article provides a comprehensive overview of Rockwell Medical Inc.'s (RMTI) quarterly and annual cash flow statements, including operating, investing, and financing activities. It details specific financial figures such as operating cash flow, capital expenditures, and free cash flow, alongside year-over-year percentage changes. The …

CABR|Caring Brands Inc|Price:1.440|Chg%:-0.010

This article provides real-time market trends, quotes, and analysis for Caring Brands Inc (CABR). As of the close on July 27, the stock traded at $1.440, reflecting a slight decrease of 0.69%. The company has a market capitalization of $21.26 million, and key shareholders …

Harrow Inc (HROW) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Harrow Inc (HROW), identifying its major shareholders and institutional holdings. It provides a breakdown of shareholder types, institutional shareholding trends over recent quarters, and recent shareholder activity with changes in holdings for key investors. The article also …

Pacira's knee gene therapy gets new-process drug for Phase 2

Pacira BioSciences has successfully transitioned its investigational gene therapy PCRX-201 for osteoarthritis of the knee to a scalable U.S.-based commercial manufacturing process. This allowed the enrollment of the first patient in Part B of the Phase 2 ASCEND study, while Part A enrollment concluded …

Talphera Inc (TLPH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Talphera Inc (TLPH) based on business segments for FY2022, as of an update on March 5, 2025. It details revenue contributions from DSUVIA and DZUVEO, noting that other segments like Zalviso and royalty revenue had no contribution. …

Talphera Inc (TLPH) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Talphera Inc (TLPH), listing its major shareholders and their respective proportions, including CorMedix Inc, Rock Springs Capital Management LP, and Rosalind Advisors, Inc. It also provides a breakdown of shareholder types such as corporations and hedge funds, …

RDY SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Dr. Reddy's Laboratories

Regencell Bioscience Holdings Ltd (RGC) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a detailed risk assessment for Regencell Bioscience Holdings Ltd (RGC), focusing on its volatility, financial risk, and investment risk. It presents various metrics such as Beta, VaR, Maximum Drawdown, Volatility, Sharpe Ratio, Skewness, and Liquidity. The data indicates significant volatility and …

HUTCHMED (China) Ltd (HCM) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of HUTCHMED (China) Ltd (HCM), detailing its support, resistance, indicators, and moving averages as of July 27, 2026. It presents a summary of various technical indicators like MACD, RSI, and KDJ, alongside moving average data, offering a "Neutral" …

Akebia Therapeutics Inc (AKBA) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Akebia Therapeutics Inc's (AKBA) stock performance, market capitalization, and dividend history. It highlights that the company has not distributed any dividends over the past five years. The page also offers general financial data and company information for AKBA.

Liquidia Corp (LQDA) Earnings Forecast: Future EPS & Revenue Growth Estimates

Liquidia Corp (LQDA) has a current earnings forecast score of 8.50, ranking 33rd in the Pharmaceuticals industry. Analysts have an average price target of $47.00 for LQDA, with most recommending a "Buy" trend. The company's expected revenue for the next quarter is $168.54 million, …

Anika Therapeutics Inc (ANIK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Anika Therapeutics Inc (ANIK) by business segment and geographical region. For the fiscal year 2025, the company's revenue was primarily driven by its OEM Channel and Commercial Channel. The United States contributed the largest portion of …

Talphera Inc (TLPH) Cash Flow

This article provides a deep dive into Talphera Inc's (TLPH) cash flow statements, offering both annual and quarterly data to assess its financial health. It details operating, investing, and financing cash flows, along with changes in working capital and free cash flow. The content …

Talphera Inc (TLPH) Income Statement

This article provides the quarterly and annual income statements for Talphera Inc (TLPH), detailed financial data including revenue, operating expenses, and net income, and a set of frequently asked questions to help users understand how to interpret the financial statements. It shows that Talphera …

Can Takeda Pharmaceutical (TSE:4502) Trade At A Discount On New Phase 3 Psoriasis Data?

Takeda Pharmaceutical (TSE:4502) has released positive Phase 3 data for its oral TYK2 inhibitor zasocitinib for plaque psoriasis, which has contributed to recent share price momentum. Despite this, the stock trades below analyst price targets and some intrinsic value estimates, suggesting it may be …

HUTCHMED (China) Ltd (HCM) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of HUTCHMED (China) Ltd (HCM) stock, focusing on its dividend and stock split history. It notes that no dividend data is available for the past five years. The page also includes current stock performance metrics and market capitalization for …